Patent ID: 11897899
Assignee: SHIONOGI & CO., LTD.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A  Y | IPC A  C

Claim 14:
15. A method for treating a disease associated with dopamine D3 receptor comprising administering an effective amount of the compound according to claim 1 or a pharmaceutically acceptable salt thereof to a patient in need thereof,
wherein the disease associated with the dopamine D3 receptor is selected from the group consisting of depression, anxiety, gambling addiction, dementias, memory impairment, schizophrenia, bipolar disorder, mania, acute mania, psychoses, attention-deficit/hyperactivity disorder (AD/HD), attention deficit disorder (ADD), obsessive-compulsive disorder (OCD), dyskinesia disorder, Parkinson's disease, neuroleptic-induced Parkinson's syndrome and tardive dyskinesia, sexual dysfunction, a learning disability, emesis, amnesia, aggression, autism, vertigo, a circadian rhythm disorder, and a gastric motility disorder.